WESTLAKE VILLAGE, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the second quarter of 2025 and provided general business updates.
Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates
Seeking Alpha / 1 hour from now 1 Views
Comments